Literature DB >> 1127731

Inhibition of metastasis in rats immunized with xenogenized autologous tumor cells after excision of the primary tumor.

H Kobayashi, E Gotohda, M Hosokawa, T Kodama.   

Abstract

Subcutaneously transplanted 3-methylcholanthrene-induced KMT-17 tumor in WKA rats yielded not only a local solid tumor but also frequent metastases in regional lymph nodes. Neither active immunization with xenogenized identical tumor cells nor surgical excision of the solid tumor prohibited the metastases when each treatment was given 4 days after tumor transplantation. However, immunization combined with surgery significantly decreased the metastases and prolonged survival.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127731

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  6 in total

1.  Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.

Authors:  C Uyttenhove; J Van Snick; T Boon
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

2.  Experimental model of serum therapy for metastasized rabbit transplantable tumors (inhibition of metastatic lesions and life-prolongation).

Authors:  K Nakano; H Tokita; H Amemiya; S Suzuki; K Ohmori; Y Kimura; N Tanaka; T Ueno
Journal:  Jpn J Surg       Date:  1980-06

3.  The improved effects of specific active immunotherapy on a rat fibrosarcoma by antitumor drugs.

Authors:  M Komatsumoto; M Hosokawa; F Okada; T Okayasu; T Tanabe; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites.

Authors:  M Hosokawa; T Mizukoshi; K Morikawa; Z Y Xu; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis.

Authors:  A Van Pel; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Downregulation of KIF23 suppresses glioma proliferation.

Authors:  Satoshi Takahashi; Noemi Fusaki; Shigeki Ohta; Yoshihiro Iwahori; Yukihiko Iizuka; Kohei Inagawa; Yutaka Kawakami; Kazunari Yoshida; Masahiro Toda
Journal:  J Neurooncol       Date:  2011-09-09       Impact factor: 4.506

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.